Xeris Biopharma Holdings, Inc. (XERS)
6.04
0.00 (0.00%)
USD |
NASDAQ |
Apr 02, 16:00
6.04
0.00 (0.00%)
After-Hours: 19:50
Xeris Biopharma Holdings Research and Development Expense (TTM) : 31.16M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 254.91M |
| Zoetis, Inc. | 698.00M |
| Harrow, Inc. | 12.49M |
| Zymeworks, Inc. | 137.00M |
| Vir Biotechnology, Inc. | 432.80M |